# Irbesartan in Type 2 Diabetes

> **NCT00317915** · PHASE3 · COMPLETED · sponsor: **Steno Diabetes Center Copenhagen**

## Conditions studied

- Type 2 Diabetes
- Microalbuminuria
- Hypertension

## Interventions

- **DRUG:** Irbesartan treatment

## Key facts

- **NCT ID:** NCT00317915
- **Lead sponsor:** Steno Diabetes Center Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2006-04-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00317915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00317915, "Irbesartan in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00317915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*